DRS310824_1.png

Tranesma 3% Gel

Therapeutic Class: BLOOD RELATED
Manufacturer:
Get Quote

Tranesma 3% Gel is used to treat melasma. Melasma is a condition in which brown-colored patches appear on the face. This medicine helps to control hyperpigmentation of the skin.Tranesma 3% Gel is an anti-fibrinolytic. It works by preventing the breakdown of clots which leads to the stoppage of bleeding. This medicine must be taken in the dose and duration as advised by the doctor. You should not take it if you have any known allergy to this medicine.The most common side effects include nausea, diarrhea, and abdominal pain. Let yor doctor know if you experience of these symptoms that persist or other you. Also, inform your doctor if you have undergone any cardiac surgery or you are suffering from any kidney disease.This medicine is safe to use in pregnant or breastfeeding mothers. It is also safe to use in patients suffering from liver diseases. It is advised not to consume alcohol after taking this medicine as there can be excessive drowsiness.

Salt Composition: Tranexamic Acid (3% w/w)
Strength: Tranexamic Acid (3% w/w)
Pack Size: tube of 30 gm Gel
Uses: Treatment of Melasma
Table Header
Salt Composition
Tranexamic Acid (3% w/w)
Strength
Tranexamic Acid (3% w/w)
Pack Size
tube of 30 gm Gel
Uses
Treatment of Melasma
DISCLAIMER
N Chimanlal Enterprises (www.pilcare.com) is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India. Product is supplied for Tenders/ Emergency imports/ Unlicensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials. Product names, logos, brands and other trademarks featured or referred to are the property of their respective Trademark Holders. The information provided here is for Informational purposes only.

Product information is meant for


WholesalersSuppliersExportersDoctorsMOH Tender SuppliesHospitalsBrandCROsComparator SuppliesGenericCooperate SourcingIndividual PatientsIndian Institutional Buyers
Recently Viewed
Categories